PM
Prasenjit Mondal
Massachusetts General Hospital, Indian Institute of Chemical Biology CSIR, Indian Institute of Technology Kanpur, Tamralipta Mahavidyalaya
Research areas: Neuroscience · Cellular and Molecular Neuroscience · Alzheimer's disease research and treatments · Analytical Methods in Pharmaceuticals · Microtubule and mitosis dynamics
Employment
-
Massachusetts General Hospital-Harvard Medical School Postdoctoral Research Scholar2019 - Present
-
Indian Institute of Chemical Biology CSIR Project Assistant-III2018 - 2019
Education
- 2013 - 2018
-
Indian Institute of Technology Kanpur Master of Science2011 - 2013
-
Tamralipta Mahavidyalaya Bachelor of Science2008 - 2011
-
American Chemical Society ACS Reviewer Lab Certificate of Completion
Projects & Funding
Projects & funding information is unavailable.
Publications (48)
- Modulating Stress Granules via HDAC6 Inhibition: A Promising Strategy against Alzheimer’s Disease Save
- Intracellular protein GBF1 displays significant associations with amyloid pathology in Alzheimer's disease Save
- Editorial: Current chemical approaches in combating neuroinflammation in Alzheimer's disease (AD) Save
- HDAC6 as a Modulator of DNA Repair in Alzheimer’s Disease: From Mechanisms to Therapeutic Perspectives Save
- Development of Carbon‐11 Labeled Pyrimidine Derivatives as Novel Positron Emission Tomography (PET) Agents Enabling Brain Sigma‐1 Receptor Imaging Save
- HDAC11 displays neuropathological alterations and offers as a novel drug target for Alzheimer's disease Save
- Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome Save
- Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease Save
- Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner Save
- Designed novel nuclear localizing anticancer peptide targets p53 negative regulator MDM2 protein Save
- Structure‐Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology Save
- Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice Save
- A Photolabile Curcumin‐Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment** Save
- Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors. Save
- Evolution of Potential Antimitotic Stapled Peptides from Multiple Helical Peptide Stretches of the Tubulin Heterodimer Interface: Helix-Mimicking Stapled Peptide Tubulin Inhibitors Save
- Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease Save
- AlGaN/GaN HEMT Based Biosensor for Detection of the HER2 Antigen Spiked in Human Serum Save
- Designed hybrid anticancer nuclear-localized peptide inhibits aggressive cancer cell proliferation Save
- A Rapid and Easy-to-Perform Method of Nucleic-Acid Based Dengue Virus Diagnosis Using Fluorescence-Based Molecular Beacons Save
- Power of an Organic Electron Acceptor in Modulation of Intracellular Mitochondrial Reactive Oxygen Species: Inducing JNK- and Caspase-Dependent Apoptosis of Cancer Cells Save